Investor · 1 deal
Every published round Tempus Partners took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| HealthMatch | Series B | 2021 | $18m | Participant | SmartCompany, Startup Daily (12 Sep 2022), Startup Daily (29 Jun 2022) |
Companies Tempus Partners has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| HealthMatch | 2021, Series B | 1 | 0 |
Fund closes reported for Tempus Partners, as distinct from the investments it has made.
Companies Tempus Partners has backed that another company then bought. An exit for the holding, not a deal Tempus Partners did.
Stories naming Tempus Partners. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Clinical trials matching startup HealthMatch halves its team, shedding 18 jobs, 18 months after a Square Peg-led raise. The piece also recalls funding for Volt and Milkrun and reports the closures of Volt and Send.
Square Peg's investment note recounts co-leading HealthMatch's $6 million Series A after an accelerated five-day process, profiling founder Manuri Gunawardena's clinical trial matching platform and existing backer Tempus Partners.